Frequency and Causes of Nocturnal Alarms in Youth and Young Adults With Type 1 Diabetes Using a First-Generation Hybrid Closed-Loop System.


Journal

Diabetes spectrum : a publication of the American Diabetes Association
ISSN: 1040-9165
Titre abrégé: Diabetes Spectr
Pays: United States
ID NLM: 8913432

Informations de publication

Date de publication:
2024
Historique:
pmc-release: 01 03 2025
medline: 17 5 2024
pubmed: 17 5 2024
entrez: 17 5 2024
Statut: ppublish

Résumé

Meeting glycemic recommendations is challenging for youth with type 1 diabetes. Diabetes technology, including continuous glucose monitoring (CGM) and hybrid closed-loop (HCL) automated insulin delivery systems, significantly increase achievement of glycemic targets; however, many youth struggle to sustain use of early HCL systems. Nocturnal alarm fatigue contributes to disrupted sleep and device discontinuation. We examined the frequency and causes of nocturnal (10:00 p.m. to 6:00 a.m.) alarms in pediatric patients ( At baseline (HCL system in nonautomated mode), participants averaged 3.3 ± 0.6 alarms per night. In the 2 weeks after starting HCL (automated) mode, alarm frequency significantly increased to 5.4 ± 0.5 times per night ( These data show that HCL system nocturnal alarms are frequent and may be barriers to sleep quality and device use. Further research is needed to assess the impact of diabetes technology on sleep and to determine method to improve sleep quality with technology use.

Sections du résumé

Background UNASSIGNED
Meeting glycemic recommendations is challenging for youth with type 1 diabetes. Diabetes technology, including continuous glucose monitoring (CGM) and hybrid closed-loop (HCL) automated insulin delivery systems, significantly increase achievement of glycemic targets; however, many youth struggle to sustain use of early HCL systems. Nocturnal alarm fatigue contributes to disrupted sleep and device discontinuation.
Methods UNASSIGNED
We examined the frequency and causes of nocturnal (10:00 p.m. to 6:00 a.m.) alarms in pediatric patients (
Results UNASSIGNED
At baseline (HCL system in nonautomated mode), participants averaged 3.3 ± 0.6 alarms per night. In the 2 weeks after starting HCL (automated) mode, alarm frequency significantly increased to 5.4 ± 0.5 times per night (
Conclusion UNASSIGNED
These data show that HCL system nocturnal alarms are frequent and may be barriers to sleep quality and device use. Further research is needed to assess the impact of diabetes technology on sleep and to determine method to improve sleep quality with technology use.

Identifiants

pubmed: 38756430
doi: 10.2337/ds23-0003
pii: DS230003
pmc: PMC11093760
doi:

Types de publication

Journal Article

Langues

eng

Pagination

118-123

Informations de copyright

© 2024 by the American Diabetes Association.

Déclaration de conflit d'intérêts

C.B. is a consultant/speaker for Insulet. L.H.M. has received speaking/consulting honoraria from Dexcom and Tandem Diabetes Care and also consults for Beta Bionics and Capillary Biomedical. R.P.W. has received research funding from Dexcom, Eli Lilly, and Tandem Diabetes Care; conference travel support from Dexcom and Eli Lilly; consulting honoraria from Eli Lilly; and speaker honoraria from Dexcom. G.P.F. conducts research sponsored by and has been a consultant/speaker for Abbott, Beta Bionics, Dexcom, Insulet, Medtronic, and Tandem Diabetes Care. No other potential conflicts of interest relevant to this article were reported.

Auteurs

Erin C Cobry (EC)

University of Colorado Anschutz Medical Campus, Barbara Davis Center for Diabetes, Aurora, CO.

Tim Vigers (T)

University of Colorado Anschutz Medical Campus, Barbara Davis Center for Diabetes, Aurora, CO.
Colorado School of Public Health, Department of Biostatistics and Informatics, Aurora, CO.

Cari Berget (C)

University of Colorado Anschutz Medical Campus, Barbara Davis Center for Diabetes, Aurora, CO.

Laurel H Messer (LH)

University of Colorado Anschutz Medical Campus, Barbara Davis Center for Diabetes, Aurora, CO.

R Paul Wadwa (RP)

University of Colorado Anschutz Medical Campus, Barbara Davis Center for Diabetes, Aurora, CO.

Laura Pyle (L)

University of Colorado Anschutz Medical Campus, Barbara Davis Center for Diabetes, Aurora, CO.
Colorado School of Public Health, Department of Biostatistics and Informatics, Aurora, CO.

Gregory P Forlenza (GP)

University of Colorado Anschutz Medical Campus, Barbara Davis Center for Diabetes, Aurora, CO.

Classifications MeSH